U of T startup Bridge7 using artificial intelligence to improve cancer treatment

Artificial intelligence (AI) is changing many industries and the applications of AI are becoming more widespread each day. Launched via the U of T Early-Stage Technology program (UTEST), Bridge7 is a startup working to apply AI “to improve the quality, consistency, and efficiency of cancer treatments.” On August 19, Bridge7 was announced as one of nine startups selected for the inaugural cohort of Canada’s Google for Startups Accelerator. The tech giant’s Global Accelerator Program was created to foster companies that focus on local issues, helping them address their specific markets and giving them access to Google’s resources.